Endo International plc (NASDAQ: ENDP), a highly focused generics and specialty branded pharmaceutical company, announced on Wednesday that it has named Mark G Barberio as its new director.

Barberio has also been appointed to the company's Audit and Nominating and Governance Committees.

Barberio is the principal of Markapital LLC. Prior to founding Markapital, he led Mark IV LLC where he served in a number of leadership positions, including as its co-chief executive officer and chief financial officer.

Paul Campanelli, Endo's chairman, president and chief executive officer, said 'In addition to Mark's senior executive leadership experience, Mark's operations, finance and strategic planning perspective on corporate growth will provide valuable insight to the board. We are pleased to welcome him to our board.'